PhD, Molecular Biology
McGill University, Canada
MSc, Applied Parasitology and Medical Entomology
Liverpool University, England
University of Nairobi, Kenya
Annete Njue, PhD, is a Director in the RTI-HS Market Access and Outcomes Strategy group in Manchester, United Kingdom. She has over 13 years of experience working in market access and medical communications. Dr. Njue is involved in leading and writing systematic and targeted literature reviews and value dossiers to support products in a variety of therapy areas. She is also involved in preparing health technology assessment (HTA) submissions for the National Institute for Health and Clinical Excellence (NICE), the Scottish Medicines Consortium (SMC), and the National Centre for Pharmacoeconomics (NCPE). She has experience in a broad range of therapy areas, including cardiovascular disease, diabetes, hematological disorders, infectious diseases, oncology (breast, lung, prostate, colorectal cancer, myeloma), mental health, ocular conditions, renal disease, reproductive disorders, and respiratory disorders. Before joining RTI HS, Dr. Njue was a Senior Medical Writer at Prime Medica Ltd. Dr. Njue previously worked in veterinary research in Canada and Kenya, and published her work in Journal of Neurochemistry, Parasitology, and Parasitology Research.